Dr Carolyn Myers is a pharmaceutical executive with over 30 years of experience in the pharmaceutical industry.
Dr Myers is the chief executive of FendX technologies, a medical technology company formed to develop and commercialise products using a unique pathogen-repelling technology. She is also principal of BioEnsemble which provides consulting services to small and mid-size pharma, biotech and medical technology companies.
Dr Myer had previously held senior leadership roles at Allergan, Forest Labs, Mylan (now Viatris) and Pharmacia (now Pfizer). She was also vice president of global alliance management and international business development at Allergan, vice president of marketing at Forest Laboratories, president of Dey Laboratories, and president of Mylan Technologies.
